Liquidia Corp
NASDAQ:LQDA

Watchlist Manager
Liquidia Corp Logo
Liquidia Corp
NASDAQ:LQDA
Watchlist
Price: 15.66 USD 3.57% Market Closed
Market Cap: 1.3B USD

Liquidia Corp
Investor Relations

Liquidia Corp. operates as a holding company which through its subsidiary engages in developing and commercializing biopharmaceutical products. The company is headquartered in Morrisville, North Carolina and currently employs 47 full-time employees. The company went IPO on 2018-07-26. PRINT technology is a particle engineering platform that enables precise production of uniform drug particles designed to improve the safety, efficacy and performance of a wide range of therapies. The firm is engaged in developing product candidates from its pipeline, LIQ861 for the treatment of pulmonary arterial hypertension (PAH) and LIQ865 for the treatment of local post-operative pain. LIQ861 is an inhaled dry powder formulation of treprostinil designed to improve the therapeutic profile of treprostinil by enhancing deep-lung delivery and achieving higher dose levels than current inhaled therapies. LIQ865, has completed a Phase Ib clinical trial, is designed to deliver sustained-release particles of bupivacaine, a non-opioid anesthetic and to treat local post-operative pain.

Show more
Loading

Earnings Calls

2025 Q4
Feb 27, 2025
Show Transcript
Previous
Next
Autodesk anticipates significant growth amidst operational restructuring and strong performance metrics.
2025 Q4
Feb 27, 2025

Autodesk reported strong fourth-quarter results with a 12% revenue increase, fueled by robust performances in AutoCAD and construction markets. For fiscal 2026, the company expects revenue growth of 8-9% and billings growth of 17-19%, excluding new transaction model impacts. GAAP operating margins are projected between 21%-22%, while non-GAAP margins will range from 39%-40%. Free cash flow is estimated between $2.075 billion and $2.175 billion. Despite restructuring efforts, Autodesk maintains confidence in its strategic direction and product innovation, particularly in clean technology and market expansion.

Show Full Analysis

Management

Dr. Roger A. Jeffs Ph.D.
CEO & Director
No Bio Available
Mr. Michael Kaseta
COO & CFO
No Bio Available
Mr. Russell Schundler
General Counsel & Corporate Secretary
No Bio Available
Dr. Ginger Denison
Co-Founder
No Bio Available
Ms. Sarah Krepp SPHR
Vice President of People & Culture
No Bio Available
Mr. Jason Adair
Chief Business Officer
No Bio Available
Mr. Scott Moomaw
Chief Commercial Officer
No Bio Available
Dr. Rajeev Saggar M.D.
Chief Medical Officer
No Bio Available
Mr. Michael Hunter
Senior Vice President of Manufacturing Operations
No Bio Available

Contacts

Address
NORTH CAROLINA
Morrisville
419 Davis Drive, Suite 100, Suite
Contacts
+19193284400.0
www.liquidia.com